Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.36 USD | +1.54% | -2.26% | +31.93% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Neutral |
Resistance | 40.12 | 40.12 | 41.68 |
Spread/Res. | -9.37% | -9.37% | -12.76% |
Spread/Supp. | +17.10% | +17.10% | +96.43% |
Support | 31.05 | 31.05 | 18.51 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- PTCT Stock
- Charts PTC Therapeutics, Inc.